Press release
What's driving the Epigenomics Market Growth? Prominent Players: Zimmer Biomet, Novartis, Abbott, Kalila Medical, Abcam, Merck, Thermo Fisher Scientific
Get PDF Brochure of this Report@ https://www.fortunebusinessinsights.com/enquiry/sample/epigenomics-market-100193
Fortune Business Insights foresees the pharmaceutical segment to dominate the global epigenomics market on account of the increasing prevalence of chronic diseases such as cancer. According to the World Health Organization (WHO), by the end of 2025, the number of cancer patients will reach 21,471,996.
This is a key factor impelling researchers for developing novel epigenomics modulators for treating, and augmenting the growth of the pharmaceuticals segment in the market for epigenomics during the forecast duration. Besides this, the rise in research and development programs for exploiting epigenetics alteration for treating cancer and other chronic diseases will help the pharmaceutical segment to generate more revenue in the coming years.
Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
• Novartis
• Abbott
• Kalila Medical
• Abcam
• Merck KGaA, Darmstadt, Germany
• Merck
• Thermo Fisher Scientific
• Zymo Research Corp
• Illumina
• Agilent Technologies
• Zimmer Biomet
• Epizyme
• Boehringer Ingelheim
Increasing Funding from Government to Help Market Gain Momentum
A major factor boosting the global epigenomics market is the rising number of cancer cases in the world, followed by rising investment in research projects in order to develop novel therapeutics for such chronic diseases. The rise in number of funds raised by the government for such research and development will help the market witness immense growth.
Rise in geriatric population and their vulnerability towards various health issues will also create lucrative growth opportunities for the market. This, coupled with growth in market for personalized medicines, is also helping the market grow remarkably. The increasing importance for epigenetic technology will help the market gain potential in the future.
Request Customization of this Report@ https://www.fortunebusinessinsights.com/enquiry/customization/epigenomics-market-100193
However, a major cause of concern for players operating in the epigenomics market is the inefficiency in validation and identification of biomarkers. This, coupled with the presence of complex regulatory framework for epigenomics may hamper the growth of the market in the long run. Again, the lack of skilled professionals in this field may also cause hindrance to the market in the long run.
On the positive side, the rising number of collaborations among companies will help the market gain momentum. Again, the increasing number of geriatric population and the rising prevalence of chronic diseases will help the market grow remarkably in the coming years.
Upgraded Therapeutic Procedures to Fuel Demand for Epigenomics in Market
Geographically, the global epigenomics market is anticipated to be dominated by North America owing to the presence of better healthcare infrastructure and proper medical facilities. Besides this, the availability of upgraded therapeutic machinery and supportive reimbursement policies for people, especially in developed nations such as Canada and the U.S. are also helping the market in the region gain dominance and continue dominating in the years to come.
Asia Pacific, on the other hand is prognosticated to show faster growth rates on account of increasing disposable income of people and introduction and implementation of advanced technology in medical technology and treatment facilities. The developing nations are trying to impose new medication therapies for better outcomes.
By Technology
· DNA Methylation
· Histone Methylation
· Histone Acetylation
· MicroRNA Modification
· Large Non-coding RNA
· Chromatin Structures
Browse Full Report@ https://www.fortunebusinessinsights.com/industry-reports/epigenomics-market-100193
By Geography
· North America (USA and Canada)
· Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
· Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
· Latin America (Brazil, Mexico and Rest of Latin America)
· Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
About Us:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release What's driving the Epigenomics Market Growth? Prominent Players: Zimmer Biomet, Novartis, Abbott, Kalila Medical, Abcam, Merck, Thermo Fisher Scientific here
News-ID: 1781097 • Views: …
More Releases from Fortune Business Insights
Reverse Flame Steam Boiler Market 2023 Dynamics, Major Players, SWOT Analysis, a …
Overview of the Global Reverse Flame Steam Boiler Market 2030:
The report discusses everything a marketer requires before investing in the global Reverse Flame Steam Boiler Market during the forecast period 2023-2030. Reverse Flame Steam Boiler Market Size, Share And Global Trend By Capacity (Up to 100kW, 100-1000 kW, Above 1000 kW), By End-Use (Food Industry, Chemical Industry, Refineries, Metal Industry, Power Plant), And Geography Forecast Till 2022-2029. It provides detailed…
Syngas and Derivatives Market Research Analysis, Size, Share, Growth Highlights …
Overview of the Global Syngas and Derivatives Market 2030:
The report discusses everything a marketer requires before investing in the global Syngas and Derivatives Market during the forecast period 2023-2030. Syngas and Derivatives Market Size, Share and Global Trend By Feedstock(Coal, Petroleum, Natural Gas, Biomass), By Technology(Partial Oxidation, Steam Reforming, Auto-Thermal Reforming, and others), By End User(Chemicals, Power Generation, Liquid Fuels, Gaseous Fuels), and Geography Forecast till 2022-2029. It provides detailed…
Port equipment Market Will Experience An Upswing In Demand, Driven By Top Player …
The Port equipment Market Research Report provides an in-depth analysis of the market landscape and identifies future growth opportunities and trends until 2030. By offering valuable insights, the report enables companies to make informed decisions on business strategies and identify potential areas for growth. With a comprehensive assessment of the market, it equips businesses with the necessary tools to stay ahead of the competition.
With this Port equipment Market research report,…
Modular Chillers Market to reach USD 6.13 billion by 2026, at a CARG of 6.2% | L …
The Modular Chillers Market Report 2023 by Fortune Business Insights provides a comprehensive overview of the market's latest trends, size, regulations, key players, and strategies. The report offers valuable insights into the market's sales and revenue, product type, applications, regions, and leading players. Modular Chillers Market report also covers key players and competitor analysis, providing a comprehensive understanding of the industry's commercial landscape. The report is useful for gaining insights…
More Releases for Epigenomics
Global Epigenomics Market: Regional Analysis and Technological Analysis till 203 …
The Global Epigenomics Market accounted for US$ 1.2 billion in 2020 and is estimated to be valued at US$ 3.9 Billion by 2030 and is anticipated to register a CAGR of 13.5%. According to the National Human Genome Research Institute, the epigenome is made up of chemical compounds and proteins that can attach to DNA and direct such actions as turning genes on or off, controlling the production of proteins…
Epigenomics Market Size, Growth, Share Statistics 2020-2026 | Key Players: Abbot …
Epigenomicss Market Research Report 2020 is a valuable supply of insightful information for business strategists with Top Countries Data. Furthermore, market size, the revenue shares of each segment and its sub-segments, as well as forecast figures are also covered in this report. The report study provides key statistics on the market status of the Epigenomics manufacturers and is a valuable source of guidance and direction for companies and individuals interested…
COVID-19 Impact On Epigenomics Market | Top Key Players: Abbott, Boehringer Inge …
Epigenomics Market 2020 - 2026 includes systematic information regarding to Epigenomics Industry. Report provides Epigenomics Industry and provides statistics and information on market dynamics, growth factors, key challenges, major drivers and restraints, opportunities and forecast 2026.
Top Key Players: Abbott, Boehringer Ingelheim, Agilent Technologies, Bayer, Thermo Fisher Scientific, Epizyme, Abcam, Zymo Research Corporation, Merck, Epigenomics, Illumina Inc., Novartis.
To know How COVID-19 Pandemic Will Impact This Market/Industry -Request a sample copy of…
How Epigenomics Market Will Dominate In Coming Years? Key Players: Thermo Fisher …
Fortune Business Insights foresees the pharmaceutical segment to dominate the global epigenomics market on account of the increasing prevalence of chronic diseases such as cancer. According to the World Health Organization (WHO), by the end of 2025, the number of cancer patients will reach 21,471,996.
Sample PDF Brochure https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/epigenomics-market-100193
The increasing prevalence of chronic diseases such as cancer is helping the global epigenomics market to emerge with remarkable market figures, finds…
Personalized Medicine and Epigenomics Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Personalized Medicine and Epigenomics Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 124 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability.
Click to view the full report TOC, figure and tables:
https://www.globalinforesearch.com/global-personalized-medicine-and-epigenomics-market_p104101.html
Epigenomics is the study of the…
Personalized Medicine and Epigenomics Market Should Reach To $12.1 billion till …
"The Latest Research Report Personalized Medicine and Epigenomics: Technologies and Global Markets provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
The global epigenomic market reached nearly $4 billion in 2014 and $4.7 billion in 2015. The market should reach nearly $12.1 billion in 2020, demonstrating a compound annual growth rate (CAGR) of 20.6% from 2015 to 2020.
North America dominated the global epigenomic…
